Navigation Links
Scientists ID Uterine Muscle Switch for Contractions
Date:11/21/2008

Finding may lead to new therapies for preterm labor

FRIDAY, Nov. 21 (HealthDay News) -- Researchers say they've found the switch that activates the uterine muscles for contraction during childbirth, a finding that may lead to therapies for preterm labor.

The molecule prostacyclin normally binds the protein IP on the surface of these uterine muscle cells, keeping them relatively inactive during pregnancy.

But researchers from Dartmouth Medical School in New Hampshire, testing uterine tissue strips from pregnant women undergoing Caesarean birth, found that agonist chemicals can stimulate IP, which then activated proteins involved in muscle contraction. The same chemicals also increased the contraction of these tissue strips in response to the hormone oxytocin.

The findings were published in the latest issue of the Journal of Clinical Investigation.

In an accompanying commentary, researchers from Newcastle University in the United Kingdom said the finding might be viewed as contentious, because prostacyclin is a smooth muscle relaxant. They explained the paradoxical observation by saying that one of the major signaling molecules produced by the uterus just prior to labor is prostacyclin.

More information

The March of Dimes has more about preterm labor.



-- Kevin McKeever



SOURCE: The Journal of Clinical Investigation, news release, Nov. 20, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. The Honorable Edward M. Kennedy, Scientists Mina J. Bissell and Susan Band Horwitz, and Philanthropist Jon M. Huntsman to Receive American Cancer Society Highest Honor for Outstanding Contributions to Cancer Fight
2. Scientists honored for contributions to cancer fight
3. United BioSource Scientists, FDA, and Other Industry Leaders Present to Risk Management and Drug Safety Summit
4. Scientists exploring new compounds to target muscular dystrophy
5. Portuguese scientists discover new mechanism that regulates formation of blood vessels
6. UCLA scientists find cell pathway driving a deadly sub-type of breast cancer
7. Leading Scientists From Around the World Headed to Kansas for Symposium on Combating Deadly Infectious Diseases
8. Cardiff scientists study acute infection in end-stage kidney disease patients
9. Scientists Unravel Mystery of Tamoxifen Resistance
10. Freezing Ovaries Preserves Fertility, Scientists Report
11. TSODs Frank Whyte Provides Negotiation Skills Training to NIH Scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... 24, 2017 , ... BayMark Health Services has been awarded ... (SAMHSA) State Targeted Response to the Opioid Crisis program. The funding, awarded ... development of a hub and spoke model for opioid treatment in California. The ...
(Date:7/24/2017)... ... July 24, 2017 , ... Every year, thousands of dedicated Higher Education and ... annual event is coupled with a dynamic theme like Camp Canvas; this year, they’ve ... InstructureCon 0017. , To extend their partnership with Canvas beyond the LMS integration, ...
(Date:7/24/2017)... ... July 24, 2017 , ... Puregraft, the global leader in ... of United States Patent Number 9,695,398 (the '398 patent) and South Korean Patent ... and '324 patents cover methods and systems for optimizing fat grafts for current ...
(Date:7/24/2017)... ... 2017 , ... Paul Vitenas, MD, FACS is excited to report that he ... attend Allergan’s recent meeting with their Plastics Advisory Board. As one of the top ... bringing a newly defined structure to the aesthetics market. Dr. Vitenas , along ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... **Presented by FDAnews and MSceppa Consulting **, Aug. 22-23, 2017 – Arlington, VA, ... Friday, July 28. , Increased FDA scrutiny and growing demands to track and ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... the development of oral drug delivery systems, announced today ... agreed to schedule an End-of-Phase II meeting with Oramed ... oral insulin capsule ORMD-0801 in the treatment of type ... secondary endpoints by indicating a statistically significant lowering of ...
(Date:7/10/2017)... , July 10, 2017  BDI Group ... and patient support services organization serving specialty pharmacies, ... the launch of four significant, value-added member programs ... insights, better manage reimbursement and improve access and ... factor therapies. ...
(Date:7/6/2017)... ThriveRx, the nutrition division of Diplomat Specialty Infusion Group, is celebrating a ... To celebrate its anniversary, ThriveRx recently launched a redesigned website ... with improved organization to create the best user experience for consumers and ... ... "We,ve made several great strides throughout the ...
Breaking Medicine Technology: